Holdings
Casdin Capital, LLC
As of Sep 30, 2026, Casdin Capital, LLC reported 47 positions worth US$2.29B. Largest: Revolution Medicines, Inc., Relay Therapeutics, Inc. and GeneDx Holdings Corp. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Revolution Medicines, Inc. | 2.58M | US$529M | no change | Sep 30, 2026 |
| Relay Therapeutics, Inc. | 16M | US$289M | no change | Sep 30, 2026 |
| GeneDx Holdings Corp. | 3.71M | US$268M | no change | Sep 30, 2026 |
| BioLife Solutions, Inc. | 4.5M | US$175M | −155K | Sep 30, 2026 |
| Illumina, Inc. | 530K | US$145M | no change | Sep 30, 2026 |
| GRAIL, Inc. | 680K | US$95.3M | +200K | Sep 30, 2026 |
| 10x Genomics, Inc. | 1.05M | US$94.9M | no change | Sep 30, 2026 |
| Standard BioTools Inc. | 88.8M | US$65.8M | no change | Sep 30, 2026 |
| Neurogene Inc. | 1.59M | US$44.1M | +40,000 | Sep 30, 2026 |
| Scholar Rock Holding Corporation | 850K | US$41.1M | +185K | Sep 30, 2026 |